High Potent Formulation for Antiviral Drug
High potent formulation for antiviral drugs can provide highly targeted therapy at lower doses, resulting in fewer side effects. In recent years, with the increasing complexity of novel drugs entering the small molecule development pipeline, there has been more research and development projects of highly potent drugs than ever before.
At BOC Sciences, we leverage our technical capabilities in chemical synthesis and extensive experience in developing and scaling up small molecule drugs from initial preclinical requirements through commercialisation into reliable ongoing supply to provide you with high potent formulation for antiviral drugs.
High Potent Pharmaceutical Development
BOC Sciences' dedicated team and facilities have the ability to develop and manufacture high potent formulations for antiviral drug for our customers in a safe, marketable, flexible,phase-appropriate manner.
- Flexibility
At BOC Sciences, the development and production of high potent formulations for antiviral drug can be paired with a variety of process considerations, and our flexible asset configuration allows us to adjust equipment configurations to handle solid, liquid, pyrogenic and other hazardous materials in a wide range of processes such as distillation, cryogenic, hydrogenation and particle assays.
- Customized
We help our customers design and develop a standard process for high potent formulations for antiviral drug that fits their specific requirements while ensuring repeatable quality, safety and efficiency.
- Dedicated facilities and equipment
High potent pharmaceutical production requires strict safety standards. We are equipped with a high containment cGMP manufacturing facility that is specifically designed for the safe handling of high potent formulations for antiviral drug.
Figure 1. High potent formulation evaluation and categorization. (David, B. 2008)
Our Features
Combining the data-driven decision and years of formulation expertise, we are able to deliver APIs to their targets in a way that meets the therapeutic and delivery needs of antiviral drugs. The formulation department of BOC Sciences is able to develop new solutions and implement them in a timely manner according to predefined specifications.
- Comprehensive technologies for delivery of high potent compounds
- Containment of amorphous solid dispersions
- Custom containment capabilities for a wide range of oral delivery technologies
- Delayed and sustained release of functional coatings for high potency APIs
- Strict safety and handling
- At BOC Sciences, operator safety is ensured through engineered solutions, containment systems, personal protective equipment and expert consultants with years of industrial EHS experience
- Highest standards of environmental protection through the evaluation of sealing systems and processes
- Eliminate the risk of cross-contamination by using single-use disposal sealing technology and specialized equipment or components
- Maintain the highest safety standards through strict procedures and training policies
Why Partner with BOC Sciences?
- We apply our years of proven expertise and experience in antiviral drug development to improve the success of your program
- Our continuously updated facilities support a range of antiviral drug analysis and manufacturing services
- BOC Sciences’ experienced team of scientists and regulatory staffs are focused on working with our clients to deliver timely and high-quality small molecule antiviral drugs
- Our partnerships with leading experts in emerging technologies allow us to apply innovative solutions to your antiviral drug research programs
Reference
- David, B. High-Potency APIs: Containment and Handling Issues. Pharmaceutical Technology. 2008. 2008(4).
※ Please kindly note that our services are for research use only.
